-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Learning to ShareAt first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.
by Lenn Robbins
-
Life After Pediatric Brain CancerSurvivors of pediatric brain or spinal cord tumors can have cognitive and physical impairments. Researchers say that these deficits can be minimized with the right interventions.
by Cheryl Platzman Weinstock
-
A New Guideline for Cervical Cancer ScreeningPhysicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
-
Being Candid About CancerAs a father with an aggressive brain cancer, I've opted against elaborate metaphors and in favor of candid speech when talking about cancer with my children.
by Adam Hayden
-
The Long-Term Effects of CancerAdolescent and young adult cancer survivors need to be monitored for delayed treatment side effects, including problems affecting the endocrine system, researchers say.
by Cheryl Platzman Weinstock
-
Some Pancreatic Cancers Are HereditaryA trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
-
Predicting Acute Myeloid LeukemiaTwo studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
by Anna Azvolinsky
-
Exploring When Breath Becomes AirJoin our Facebook group to talk about themes in the poignant memoir by Paul Kalanithi.
by Marci A. Landsmann
-
Forward Look
From Cold Virus to Cancer FighterNeurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
